Conversion to Dementia among Two Groups with Cognitive Impairment

Objective: To determine the conversion rates to dementia in patients diagnosed with mild cognitive impairment (MCI) thought to be caused by incipient Alzheimer’s disease (MCI-AD) or with MCI with features of vascular disease (MCI-Vas). Methods: On the basis of patient history, neurocognitive, neurological and MRI evaluation, 99 patients were diagnosed with MCI-AD and 35 with MCI-Vas. Conversion to dementia over an average of a 2.4 ± 1.8-year period was determined. Results: Over the follow-up period, 44% converted to dementia, 51.5% remained classified as MCI, and 4.5% were reclassified as cognitively normal. The conversion rate to dementia was significantly faster at 3 years for the MCI-AD (50.5%) than for the MCI-Vas group (25.7%). The neuropsychological test found to best differentiate converters from non-converters was the Fuld-OME, a measure of learning and recall. Age, education, gender or APOE Ε4 allele frequency did not differentiate converters from non-converters. Conclusions: MCI-AD and MCI-Vas are clinically meaningful subtypes of MCI that may convert to dementia at different rates. Prospective studies on larger subsets of MCI patients are required to confirm these findings.

[1]  V Hachinski,et al.  Progression of impairment in patients with vascular cognitive impairment without dementia , 2001, Neurology.

[2]  R. Petersen,et al.  Mild cognitive impairment: transition between aging and Alzheimer's disease. , 2000, Neurologia.

[3]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[4]  V. Hachinski,et al.  Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. , 2000, Neurology.

[5]  A Drzezga,et al.  Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. , 2002, Archives of neurology.

[6]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[7]  G. Small,et al.  Predictors of cognitive change in middle-aged and older adults with memory loss. , 1995, The American journal of psychiatry.

[8]  H. Ross,et al.  A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease , 2000, Neurology.

[9]  D. Loewenstein,et al.  Utility of a modified mini‐mental state examination with extended delayed recall in screening for mild cognitive impairment and dementia among community dwelling elders , 2000, International journal of geriatric psychiatry.

[10]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[11]  Oscar L. Lopez,et al.  Risk Factors for Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.

[12]  M. Samuel,et al.  Efficacy and Safety of OK-432 Sclerotherapy for Giant Cystic Hygroma in a Newborn , 2000, Fetal Diagnosis and Therapy.

[13]  M. Freedman,et al.  Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium? , 1994, Annals of neurology.

[14]  H. Tuokko,et al.  Five-year follow-up of cognitive impairment with no dementia. , 2003, Archives of neurology.

[15]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[16]  V. Gallai†,et al.  Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. , 2003, Archives of neurology.

[17]  M. B. Bender,et al.  Unilateral spatial agnosia (inattention) in patients with cerebral lesions. , 1956, Brain : a journal of neurology.

[18]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[19]  P. S. St George-Hyslop,et al.  A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics , 1999, Neurology.

[20]  W. Markesbery,et al.  White matter volumes and periventricular white matter hyperintensities in aging and dementia , 2000, Neurology.

[21]  V. Hachinski,et al.  Prevalence and outcomes of vascular cognitive impairment , 2000, Neurology.

[22]  M. Albert,et al.  Preclinical prediction of AD using neuropsychological tests , 2001, Journal of the International Neuropsychological Society.

[23]  D. Zaitchik,et al.  Predicting conversion to Alzheimer disease using standardized clinical information. , 2000, Archives of neurology.

[24]  E. Kaplan,et al.  The assessment of aphasia and related disorders , 1972 .

[25]  C. Reynolds,et al.  Wechsler memory scale-revised , 1988 .

[26]  Ronald C. Petersen,et al.  Definition, course, and outcome of mild cognitive impairment , 1996 .

[27]  Karen Ritchie,et al.  Classification criteria for mild cognitive impairment: A population-based validation study , 2001 .

[28]  Janice E Graham,et al.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population , 1997, The Lancet.

[29]  P. Celsis,et al.  Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease? , 2000, Annals of medicine.

[30]  D. Schaid,et al.  Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.

[31]  J. Schneider,et al.  Relation of cerebral infarctions to dementia and cognitive function in older persons , 2003, Neurology.

[32]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[33]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[34]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[35]  J. Hodges,et al.  Fate of Patients with Questionable (Very Mild) Alzheimer’s Disease: Longitudinal Profiles of Individual Subjects’ Decline , 2000, Dementia and Geriatric Cognitive Disorders.

[36]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[37]  W. Bowen,et al.  Philadelphia , 1892 .

[38]  P. S. St George-Hyslop,et al.  Prediction of probable Alzheimer's disease in memory-impaired patients , 1996, Neurology.

[39]  A. Acevedo,et al.  The utility of a modified Object Memory Test in distinguishing between different age groups of Alzheimer’s disease patients and normal controls , 2001 .

[40]  S H Ferris,et al.  Neuropsychological Prediction of Decline to Dementia in Nondemented Elderly , 1999, Journal of geriatric psychiatry and neurology.

[41]  Richard Camicioli,et al.  Independent predictors of cognitive decline in healthy elderly persons. , 2002, Archives of neurology.

[42]  R. Nass,et al.  The assessment of aphasia and related disorders By Harold Goodglass and edith kaplan philadelphia, lea & febiger, 1983 illustrated, $27.50 (package) , 1984 .

[43]  C. Perry.  Clinical Features , 2004, Bristol medico-chirurgical journal.

[44]  D A Grayson,et al.  Preclinical syndromes predict dementia: the Sydney older persons study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[45]  H. Amièva,et al.  Incidence and outcome of mild cognitive impairment in a population-based prospective cohort , 2002, Neurology.

[46]  J. Fisk,et al.  Societal Costs of Vascular Cognitive Impairment in Older Adults , 2002, Stroke.

[47]  Walter Kukull,et al.  Progression to dementia in patients with isolated memory loss , 1997, The Lancet.